Investigating the role of human papillomavirus in lung cancers among HIV-positive individuals
Official title: Human papillomavirus in HIV associated lung cancers
Funded at Tulane University of Louisiana · NIH-11051154 · Data updated 2026-11-12
This study is looking into how the human papillomavirus (HPV) might be linked to lung cancer in people living with HIV, using advanced techniques to analyze data from over 1,000 lung cancer samples to help improve our understanding of this connection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | April 1, 2021 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $347,257 |
| NIH project number | 5R01CA261258-05 |
| Project ID | NIH-11051154 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV who are at risk for or diagnosed with lung cancer.
✕Less likely to help
Patients who do not have HIV or lung cancer are unlikely to benefit from this research.
What this research studies
This research focuses on understanding how human papillomavirus (HPV) may contribute to lung cancers in individuals living with HIV. By analyzing over 1,000 lung cancer RNA-sequencing datasets, the researchers aim to uncover the potential causal relationship between HPV and lung cancer in this population. The study employs advanced sequencing techniques and newly developed model systems to explore this association, which could lead to better insights into the mechanisms behind lung cancer in HIV-positive patients.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for lung cancer in HIV-positive individuals.
How similar studies have gone: Previous research has indicated potential links between viral infections and various cancers, suggesting that this investigation into HPV's role in lung cancer among HIV-positive individuals is both relevant and necessary.
Where this research is happening
-
Tulane University of Louisiana
New Orleans, United States Active
Researchers
- Principal investigator: Lin, Zhen — Tulane University of Louisiana
- Study coordinator: Lin, Zhen
Related research
Other NIH-funded projects on the same topics.
-
TRIM28 Inhibition for NOTCH2-Mutant Small Cell Lung Cancer
A new approach aims to exploit a weakness in a subset of small cell lung cancer by turning on immune-related signals when NOTCH2 is lost, potentially making tumors more visible to the immune system.
-
Genomic factors shaping lung cancer risk in Native Hawaiians and Pacific Islanders
This NIH grant focuses on understanding why Native Hawaiians, Pacific Islanders, and African Americans have higher lung cancer risk and poorer outcomes by studying tumor DNA and related molecular patterns.
-
PD-L1 PET tracer to guide immune therapy in non-small cell lung cancer
A Johns Hopkins team is testing a Gallium-68 PET tracer to better guide immune checkpoint therapy for people with non-small cell lung cancer.
-
Targeting SMARCA2 to treat lung cancers that lack SMARCA4
This work looks at whether blocking a protein called SMARCA2 can slow or stop lung cancers that have lost the related gene SMARCA4.
-
New medicines for lung cancers caused by KRAS or BRAF changes
Testing new medicines that block ERK/RAF signaling in people with lung cancer driven by KRAS or BRAF mutations.
-
Understanding lung cancer risks in Native Hawaiians
This research looks at the genetic differences in lung cancer among Native Hawaiians to better understand why they face higher risks and poorer outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.